London midday: Miners provide a drag on Footsie
10th Apr 2012 11:53
- Friday's US jobs data dampens sentiment - Rising exports push China into trade surplus - Randgold bounces back after Malian settlement The Footsie had fallen by nearly one whole percentage point by Tuesday lunchtime as investors digested a gloomy jobs report from the US which came out on Friday.
Read moreLondon open: Stocks slip after QE3 hopes fade
4th Apr 2012 08:21
- ECB to hold rates - Pearson and host of ex-div stocks fall - Kentz drops after major shareholder slashes stake UK stocks fell into the red on Wednesday morning after the US Federal Reserve quashed speculation that it would start another round of quantitative easing (QE) in the near-future. US be
Read moreSector movers: Thos. Cook drags travel sector south
3rd Apr 2012 14:37
London has been enjoying a sleepy day, with no major blockbusting moves among the blue-chips. There has been a bit of news-flow affecting the pharmaceuticals sector, with drugs developers Glaxo and Astra both announcing developments. GlaxoSmithKline has received top-line results from seven of the
Read moreLondon midday: Whitbread blows froth off Costa speculation
3rd Apr 2012 11:47
The Footsie moved sideways in the morning session, prompting the suspicion that many traders have made an early start to the Easter break. Food - and drink - for thought Whitbread's Chief Executive Officer, Andy Harrison, moved to damp down speculation about the possibility of the Premier Inn and
Read moreLondon open: Heritage bubbles higher on Iraqi success
3rd Apr 2012 08:51
London has started on the front foot, taking heart from the late surge on Wall Street yesterday, which was sparked by a better-than-expected performance by the Institute of Supply Management's manufacturing index. Drugs firms in focus Drugs giant GlaxoSmithKline has received top-line results fro
Read moreAstra to back Amgen development
3rd Apr 2012 07:16
Anglo-Swedish drugs giant AstraZeneca is teaming up with US biotechnology company Amgen to jointly develop and bring to market a portfolio of clinical-stage inflammation treatments. The pair will work on five monoclonal antibodies from Amgen's clinical inflammation portfolio: AMG 139, AMG 157, AMG
Read moreLondon close: Stocks rise as euro leaders boost firewall
30th Mar 2012 16:32
- Eurozone to boost firewall to 800bn euros - Spain cuts 27bn euros from the budget - Petrofac up after broker comments, Shire leads the fallers London's blue chip index finished the day strongly after Eurozone leaders agreed to strengthen the firewall to protect the debt crisis from spreading. Som
Read moreLondon midday: Stocks rise as eyes turn to Eurozone meeting
30th Mar 2012 11:42
- Investors keep a close eye on meeting in Copenhagen - Eurozone inflation falls but still high - Miners lead the rise by lunchtime The Footsie was making decent gains by Friday lunchtime, snapping a three-day losing streak, as Eurozone ministers meet in Copenhagen to discuss a potential increase i
Read moreLondon open: Stocks rise ahead of Eurozone meeting
30th Mar 2012 08:33
- Footsie up before finance ministers meet - Greek PM doesn't rule out third bailout - Miners rise strongly after recent fall London's blue chips started strongly on Friday following a three-day decline for the FTSE 100, with miners leading the way tracking metals prices higher. Eyes are on the E
Read moreLondon pre-open: Stocks to open up ahead of Eurozone meeting
30th Mar 2012 07:34
City sources predict the FTSE 100 will open up 38 points from yesterday's close of 5,742, as market sentiment grows ahead of today's meeting of Eurozone finance ministers who will discuss whether or not to increase the region's bailout fund. Sweeteners giant Tate and Lyle said trading in the final
Read moreUS court sides with Astra on SEROQUEL
30th Mar 2012 07:12
Drugs giant AstraZeneca has had a bad run of late so news that a US District Court has ruled that the formulation patent protecting its SEROQUEL XR blockbuster drug is valid will be most welcome. The US District Court for the District of New Jersey also ruled that generic drugs makers Anchen Pharma
Read moreLondon midday: German Ifo survey lifts the mood
26th Mar 2012 11:37
- Germany's IFO index rises for fifth straight month - Concerns about Spain still on investors' minds - Aberdeen leads rise on FTSE 100, Ophir surges on FTSE 250 UK stocks managed to extend gains by Monday lunchtime after a confidence survey from Germany rose to a seven-month high. Germany's Ifo b
Read moreLondon open: Eurozone worries hold back stocks
26th Mar 2012 08:30
- European markets cautious, Spanish index drops - Germany may back an increased firewall - Abderdeen advances after pre-close trading update Stocks edged higher on Monday morning, but gains were only moderate as concerns over Europe weighed on sentiment. The STOXX Europe 600 Index lost a total o
Read moreLondon pre-open: Reports of increased bailout fund boosts FTSE
26th Mar 2012 07:37
City sources predict the FTSE 100 will open up 18 points from Friday's close of 5,855, following reports that Angela Merkel, the German Chancellor, has agreed temporary measures to increase Europe's bailout fund in a bid to soothe troubled markets. A US court has dismissed AstraZeneca's lawsuit a
Read moreAstra's injunction against the FDA denied by US court
26th Mar 2012 07:01
A US court has dismissed AstraZeneca's lawsuit against the Food and Drug Administration (FDA) which sought to delay the marketing approval of genetic copies of a quetiapine drug. SEROQUEL and SEROQUEL XR tablets, also known as 'quetiapine fumarate', are an antispsychotic drug used in the treatment
Read more